1974 Federal Register / Vol. 86, No. 6 / Monday, January 11, 2021 / Notices 

by negotiation, this clause requires 

contractors to require subcontractors to 

submit certified cost or pricing data. 

c. 52.215–13, Subcontractor Certified 

Cost or Pricing Data—Modifications. 

When contracting by negotiation, this 

clause requires contractors to require 

subcontractors to submit certified cost 

or pricing data for a modification 

involving a pricing adjustment expected 

to exceed the threshold for submission 

of certified cost or pricing data at FAR 

15.403–4(a)(1). 

d. 52.215–20, Requirements for 

Certified Cost or Pricing Data and Data 

Other Than Certified Cost or Pricing 

Data. When contracting by negotiation, 

this provision requires offerors, if not 

granted an exception, to prepare and 

submit certified cost or pricing data, 

data other than certified cost or pricing 

data, and supporting attachments in 

accordance with the instructions 

contained in Table 15–2 of FAR 15.408, 

unless the contracting officer and the 

contractor agree to a different format. 

e. 52.215–21, Requirements for 

Certified Cost or Pricing Data and Data 

Other Than Certified Cost or Pricing 

Data—Modifications. When contracting 

by negotiation, this clause requires 

contractors, if not granted an exception, 

to submit, for a modification or price 

adjustment expected to exceed the 

threshold set forth at FAR 15.403– 

4(a)(1), certified cost or pricing data, 

data other than certified cost or pricing 

data, and supporting attachments in 

accordance with the instructions 

contained in Table 15–2 of FAR 15.408, 

unless the contracting officer and the 

contractor agree to a different format. 

Certified cost or pricing data is used 

by agencies to assure that contract 

prices and any subsequent contract 

modifications are fair and reasonable. 

C. Annual Burden 

Respondents: 28,399. 

Annual Responses: 148,094. 

Total Burden Hours: 9,160,160. 

D. Public Comment 

A 60-day notice was published in the 

Federal Register at 85 FR 71077, on 

November 6, 2020. No comments were 

received. 

Obtaining Copies: Requesters may 

obtain a copy of the information 

collection documents from the GSA 

Regulatory Secretariat Division by 

calling 202–501–4755 or emailing 

GSARegSec@gsa.gov. Please cite OMB 

Control No. 9000–0013, Certified Cost or 

Pricing Data and Data Other Than 

Certified Cost or Pricing Data. 

William F. Clark, 

Director, Office of Government-wide 

Acquisition Policy, Office of Acquisition 

Policy, Office of Government-wide Policy. 

[FR Doc. 2021–00264 Filed 1–8–21; 8:45 am] 

BILLING CODE 6820–EP–P 

DEPARTMENT OF DEFENSE 

GENERAL SERVICES 

ADMINISTRATION 

NATIONAL AERONAUTICS AND 

SPACE ADMINISTRATION 

[OMB Control No. 9000–0153; Docket 2020– 

0053; Sequence No. 15] 

Submission for OMB Review; 

Alternatives to Government-Unique 

Standards 

AGENCY: Department of Defense (DOD), 

General Services Administration (GSA), 

and National Aeronautics and Space 

Administration (NASA). 

ACTION: Notice. 

SUMMARY: Under the provisions of the 

Paperwork Reduction Act, the 

Regulatory Secretariat Division has 

submitted to the Office of Management 

and Budget (OMB) a request to review 

and approve a revision and extension of 

a previously approved information 

collection requirement concerning 

alternatives to Government-unique 

standards. 

DATES: Submit comments on or before 

February 10, 2021. 

ADDRESSES: Written comments and 

recommendations for this information 

collection should be sent within 30 days 

of publication of this notice to 

www.reginfo.gov/public/do/PRAMain. 

Find this particular information 

collection by selecting ‘‘Currently under 

Review—Open for Public Comments’’ or 

by using the search function. 

Additionally, submit a copy to GSA 

through https://www.regulations.gov 

and follow the instructions on the site. 

This website provides the ability to type 

short comments directly into the 

comment field or attach a file for 

lengthier comments. 

Instructions: All items submitted 

must cite OMB Control No. 9000–0153, 

Alternatives to Government-Unique 

Standards. Comments received 

generally will be posted without change 

to https://www.regulations.gov, 

including any personal and/or business 

confidential information provided. To 

confirm receipt of your comment(s), 

please check https://

www.regulations.gov approximately 

two-to-three days after submission to 

verify posting. If there are difficulties 

submitting comments, contact the GSA 

Regulatory Secretariat Division at 202– 

501–4755 or GSARegSec@gsa.gov. 

FOR FURTHER INFORMATION CONTACT: 

Jennifer Hawes, Procurement Analyst, at 

telephone 202–969–7386, or 

jennifer.hawes@gsa.gov. 

SUPPLEMENTARY INFORMATION: 

A. OMB control number, Title, and 

any Associated Form(s): 9000–0153, 

Alternatives to Government-Unique 

Standards. 

B. Need and Uses 

This clearance covers the information 

that offerors must submit to comply 

with the provision at Federal 

Acquisition Regulation (FAR) 52.211–7, 

Alternatives to Government-Unique 

Standards. This solicitation provision 

permits offerors to propose alternatives 

to Government-unique standards in 

response to Government solicitations. If 

an alternative standard is proposed, the 

offeror must furnish data and/or 

information regarding the alternative in 

sufficient detail for the Government to 

determine if it meets the Government’s 

requirements. The information collected 

from offerors will be used by Federal 

agencies to determine if voluntary 

consensus standards will satisfy the 

Government’s needs for a particular 

solicitation, in order to comply with 

OMB Circular A–119, Federal 

Participation in the Development and 

Use of Voluntary Consensus Standards 

and in Conformity Assessment 

Activities, and Section 12(d) of the 

National Technology Transfer and 

Advancement Act of 1995 (Pub. L. 104– 

113, 15 U.S.C. 272 note). 

This OMB Control Number was 

previously entitled ‘‘OMB Circular A– 

119,’’ but has been updated to reflect the 

information collection requirement. 

C. Annual Burden 

Respondents: 100. 

Total Annual Responses: 100. 

Total Burden Hours: 100. 

D. Public Comment 

A 60-day notice was published in the 

Federal Register at 85 FR 70622, on 

November 5, 2020. No comments were 

received. 

Obtaining Copies: Requesters may 

obtain a copy of the information 

collection documents from the GSA 

Regulatory Secretariat Division by 

calling 202–501–4755 or emailing 

GSARegSec@gsa.gov. Please cite OMB 


jbell on DSKJLSW7X2PROD with NOTICES
Federal Register / Vol. 86, No. 6 / Monday, January 11, 2021 / Notices 1975 

Control No. 9000–0153, Alternatives to 

Government-Unique Standards. 

William F. Clark, 

Director, Office of Government-Wide 

Acquisition Policy, Office of Acquisition 

Policy, Office of Government-Wide Policy. 

[FR Doc. 2021–00265 Filed 1–8–21; 8:45 am] 

BILLING CODE 6820–EP–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP)—RFA–CK–21– 

001, US Travelers Health Research, 

Surveillance, Communication, and 

Outreach Network; RFA–CK–21–002, 

Emerging Infections Network— 

Research for Preventing, Detecting, 

and Managing Travelers who Acquire 

Infectious Diseases Abroad; and RFA– 

CK–21–003, Monitoring Cause-specific 

School Absenteeism for Estimating 

Community-wide Influenza and SARSCoV–2 Transmission; Amended Notice 

of Meeting 

Notice is hereby given of a change in 

the meeting of the Disease, Disability, 

and Injury Prevention and Control 

Special Emphasis Panel (SEP)—RFA– 

CK–21–001, US Travelers Health 

Research, Surveillance, Communication, 

and Outreach Network; RFA–CK–21– 

002, Emerging Infections Network— 

Research for Preventing, Detecting, and 

Managing Travelers who Acquire 

Infectious Diseases Abroad; and RFA– 

CK–21–003, Monitoring Cause-specific 

School Absenteeism for Estimating 

Community-wide Influenza and SARSCoV–2 Transmission; February 10–11, 

2021, 10:00 a.m.—5:00 p.m., EST. 

Teleconference, Centers for Disease 

Control and Prevention, Room 1080, 8 

Corporate Square Blvd., Atlanta, GA 

30329 which was published in the 

Federal Register on November 30, 2020, 

Volume 85, Number 230, pages 76575– 

76576. 

The meeting is being amended to 

change the meeting date to February 10, 

2021. The meeting is closed to the 

public. 

FOR FURTHER INFORMATION CONTACT: 

Gregory Anderson, M.S., M.P.H., 

Scientific Review Officer, CDC, 1600 

Clifton Road, NE, Mailstop US8–1, 

Atlanta, Georgia 30329–4027, (404) 718– 

8833, ganderson@cdc.gov. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2021–00280 Filed 1–8–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended, and the Determination of 

the Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, CDC, pursuant to 

Public Law 92–463. The grant 

applications and the discussions could 

disclose confidential trade secrets or 

commercial property such as patentable 

material, and personal information 

concerning individuals associated with 

the grant applications, the disclosure of 

which would constitute a clearly 

unwarranted invasion of personal 

privacy. 

Name of Committee: Disease, 

Disability, and Injury Prevention and 

Control Special Emphasis Panel (SEP)— 

RFA–PS–21–002, Implementation 

Research Consortium to Accelerate 

Impact of Health Department-Delivered 

HIV Prevention Activities. 

Date: March 23, 2021. 

Time: 10:00 a.m.–5:00 p.m., EDT. 

Place: Teleconference, Centers for 

Disease Control and Prevention, Room 

1080, 8 Corporate Square Boulevard, 

Atlanta, Georgia 30329–4027. 

Agenda: To review and evaluate grant 

applications. 

FOR FURTHER INFORMATION CONTACT: 

Gregory Anderson, M.S., M.P.H., 

Scientific Review Officer, CDC, 1600 

Clifton Road, NE, Mailstop US8–1, 

Atlanta, Georgia 30329–4027, (404) 718– 

8833, ganderson@cdc.gov. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2021–00284 Filed 1–8–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended, and the Determination of 

the Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, CDC, pursuant to 

Public Law 92–463. The grant 

applications and the discussions could 

disclose confidential trade secrets or 

commercial property such as patentable 

material, and personal information 

concerning individuals associated with 

the grant applications, the disclosure of 

which would constitute a clearly 

unwarranted invasion of personal 

privacy. 

Name of Committee: Disease, 

Disability, and Injury Prevention and 

Control Special Emphasis Panel (SEP)— 

Funding Opportunity Announcement 

(FOA), PAR 20–280, Cooperative 

Research Agreements to the World 

Trade Center Health Program (U01); and 

RFA OH–21–004, Exploratory/ 

Developmental Grants Related to the 

World Trade Center Health Program 

(R21). 

Dates and Times: March 16–17, 2021, 

from 9:00 a.m.–6:00 p.m., EDT; and 

March 18, 2021, from 9:00 a.m.–12:00 

p.m., EDT. 

Place: Virtual. 

Agenda: To review and evaluate grant 

applications. 

FOR FURTHER INFORMATION CONTACT: 

Marilyn Ridenour, B.S.N., M.B.A., 

M.P.H., C.P.H., C.I.C., CAPT, USPHS, 

Scientific Review Officer, CDC, National 


jbell on DSKJLSW7X2PROD with NOTICES